https://www.ispor.org/vih-articles/Volume-25--Supplemental-Issue-12S/EE370-Cost-Effectiveness-Evaluation-of-Dapagliflozin-in-the-Treatment-of-Chronic-Kidney-Disease-in-Mexico
EE370 Cost Effectiveness Evaluation of Dapagliflozin in the Treatment of Chronic Kidney Disease in...
cost effectiveness